Soft Tissue Sarcoma Committee of the Children's Oncology Group

Author PubWeight™ 7.00^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.	Pediatr Blood Cancer	2004	1.75
2	Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.	Pediatr Dev Pathol	2004	1.19
3	Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.	J Clin Oncol	2007	1.13
4	Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group.	Int J Radiat Oncol Biol Phys	2010	1.10
5	Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.	Eur J Cancer	2004	1.03
6	Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.	Am J Surg Pathol	2007	0.93